CMR Naviscan is a leader in organ-specific molecular imaging and part of the  Compañía Mexicana de Radiología CGR, S.A. de C.V.  (CMR) family of companies.  CMR is a major developer and manufacturer of high quality diagnostic imaging equipment that contributes to healthcare improvements through a technological innovation framework.  This includes the conversion, storage, processing and distribution of diagnostic imaging in digital form. 

CMR Naviscan is headquartered in Carlsbad, California, is US FDA registered and ISO 13485:2012 certified.  Our flag ship product, the Solo II™ High Resolution Breast PET scanner, detects breast cancers as small as 1.6 mm.  Solo II is the industry leader in terms of its sensitivity and specificity in characterizing the extent and location(s) of previously diagnosed breast cancers.